Multiparametric magnetic resonance imaging/transrectal ultrasound fusion-guided prostate biopsy: A comparison with systematic transrectal ultrasound-guided prostate biopsy

Abstract

Background & Aims. Prostate biopsy is the standard method for diagnosing prostate cancer. Herein we compared the cancer detection rate of extended systematic Transrectal Prostate Biopsy with that of multiparametric Magnetic Resonance Imaging/Transrectal ultrasound fusion-guided Prostate Biopsy. Methods. Outcomes of 99 fusion prostate biopsy (Group A) were compared with those of a matched population of patients having undergone systematic transrectal prostate biopsy (Group B) in the same period. Results. The overall cancer detection rate was 60.6% in Group A and 29,2% in Group B (p = 75y. Conclusions. Multiparametric Magnetic Resonance Imaging/transrectal ultrasound fusion-guided biopsy provided better prostate cancer detection rates than standard Prostate Biopsy in the setting of both first and repeated Prostate Biopsy, showing good correlation between Prostate Imaging-Reporting and Data System scores and cancer detection rates but complications were more common in elderly patients